Ebola has once again cropped up in Uganda and the Democratic Republic of the Congo. We’ve contained the disease before. But ...
In the past, the possibility of endemic Ebola was unthinkable. This time is different, write Ivan Buendia Gayton and Eric D.
Join us at 1 p.m. EST July 22 to learn more about his series on the soaring costs of employer-based health insurance.
America’s employers must stop acting helpless in the face of health care industry profiteering, Chris Deacon says.
Read the 5 key takeaways from STAT's series "Out of Pocket, Out of Reach," an examination of workplace health insurance.
Gen Z physicians are on a collision course with institutions still built around older assumptions,” writes Frantz M. Berthaud ...
A new secret-shopper study found that GLP-1 prescriptions from telehealth sites aren't often backed by appropriate clinical ...
States across the country saw steep drops in the number of people covered by the Affordable Care Act over the past year, ...
Vertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorder ...
Call AI in biotech hype at your peril. There are real reasons that pharmaceutical companies are embracing this technology ...
WASHINGTON — Clinical trial policy got caught up in the Trump administration’s attack on policies related to diversity, ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Good morning, and welcome to a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results